Lv4
620 积分 2023-07-24 加入
Efficacy of Upfront Docetaxel With Androgen Deprivation Therapy for Castration-Sensitive Metastatic Prostate Cancer Among Minority Patients
3小时前
已完结
Clinical effectiveness of docetaxel for castration‐sensitive prostate cancer in a real‐world population‐based analysis
3小时前
已完结
Real-world evaluation of upfront docetaxel in metastatic castration-sensitive prostate cancer
4小时前
已关闭
Addition of docetaxel or abiraterone to androgen deprivation therapy in metastatic hormone-sensitive prostate cancer in Indian population
4小时前
已完结
Androgen-deprivation therapy alone or with docetaxel in non-castrate metastatic prostate cancer (GETUG-AFU 15): a randomised, open-label, phase 3 trial
4小时前
已完结
Androgen Deprivation Therapy (ADT) Plus Docetaxel Versus ADT Alone in Metastatic Non castrate Prostate Cancer: Impact of Metastatic Burden and Long-term Survival Analysis of the Randomized Phase 3 GETUG-AFU15 Trial
4小时前
已完结
Abiraterone acetate plus prednisone in patients with newly diagnosed high-risk metastatic castration-sensitive prostate cancer (LATITUDE): final overall survival analysis of a randomised, double-blind, phase 3 trial
4小时前
已完结
Genetically Engineered Cytomembrane Nanovaccines for Cancer Immunotherapy
1个月前
已完结
A nanovaccine for antigen self-presentation and immunosuppression reversal as a personalized cancer immunotherapy strategy
1个月前
已完结
Surface charge critically affects tumor penetration and therapeutic efficacy of cancer nanomedicines
1个月前
已完结
皖公网安备34019202002308
